AnaptysBio

AnaptysBio is a clinical-stage biotechnology company focused on developing innovative immunology therapeutics. They are dedicated to addressing unmet medical needs in autoimmune and inflammatory diseases by creating immune cell modulators, including checkpoint agonists. Their pipeline includes several promising candidates in various stages of clinical development, such as ANB032, a BTLA agonist being investigated for atopic dermatitis, and rosnilimab, a PD-1 agonist with potential applications in rheumatoid arthritis and ulcerative colitis. AnaptysBio is also developing two cytokine antagonists, imsidolimab and etokimab, which are available for out-licensing.

The company is led by a strong management team with extensive experience in antibody discovery, development, and commercialization. AnaptysBio is committed to transforming patient health by delivering innovative immunology therapeutics while maintaining transparency, accountability, and humility. They are proud to offer a fulfilling work environment, evidenced by their "Best Place to Work" recognition from BioSpace. AnaptysBio is a company that is striving to make a real difference in the lives of patients with autoimmune and inflammatory diseases.

AnaptysBio is committed to providing flexibility to its employees. This includes offering generous time off benefits, including 15 vacation days per year, company holidays, and a winter closure. They also offer tuition reimbursement and ongoing course offerings to promote personal growth. Additionally, the company provides breakfast, lunch, and snacks daily to encourage healthy eating and social interaction among colleagues.

AnaptysBio offers a comprehensive benefits package designed to support employee well-being and financial security. Their health and welfare benefits include comprehensive medical, dental, and vision coverage, as well as a flexible spending account and an employee assistance program. The company also provides financial benefits such as a generous 401k match program, equity awards, and an employee stock purchase plan. To promote engagement, AnaptysBio offers generous time off, tuition reimbursement, ongoing learning and development opportunities, company-provided meals, and a variety of social events and tournaments.

AnaptysBio is a clinical-stage biotechnology company dedicated to transforming patient health through the development of innovative immunology therapeutics. Focused on addressing unmet medical needs in autoimmune and inflammatory diseases, AnaptysBio develops best-in-class antibodies that modulate immune cell function, restoring balance and dampening the inflammatory response. Their mission is guided by core values of transparency, accountability, and humility, ensuring ethical and impactful approaches to discovering and developing medicines that improve patient lives.

AnaptysBio emphasizes a collaborative and engaging work environment built on core values of transparency, accountability, and humility. The company prioritizes open communication, cross-functional teamwork, and a culture of learning and growth. They offer generous benefits and engage employees through company-sponsored events and philanthropic activities, fostering a sense of community and shared purpose.

AnaptysBio is committed to fostering a diverse and inclusive workplace where all employees feel valued, respected, and empowered. They recognize the importance of a diverse workforce to drive innovation and success, and they are actively working to create a culture of belonging where everyone has the opportunity to contribute their unique talents and perspectives. AnaptysBio strives to ensure equal employment opportunities regardless of race, color, ancestry, religion, sex, national origin, sexual orientation, age, citizenship, marital status, disability, gender identity, or veteran status. They are actively working to create a more equitable workplace by providing opportunities for professional development and advancement to all employees, regardless of background or identity.